Institut Paoli Calmettes Extends Partnership with SOPHiA GENETICS

/PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in Data-Driven Medicine, have announced, in conjunction with Assises de Génétique, an extension of...

Related Keywords

Boston ,Massachusetts ,United States ,Switzerland ,France ,French ,Institut Paoli Calmettes ,Jurgi Camblong ,Instagram ,Reference Medical Biology Laboratory ,Linkedin ,Twitter ,Nasdaq ,Exchange Commission ,Research Use ,French Cancer Comprehensive Centers ,Oncogenetic Team At Institut Paoli Calmettes ,Data Driven Medicine ,Cancer Comprehensive Centers ,Hereditary Cancer ,Set Up Program ,Genomic Instability Index ,Homologous Recombination Deficiency ,Oncogenetic Team ,Institut Paoli ,Research Use Only ,Looking Statements ,Sophia Genetics ,